🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users injecting products of uncertain source.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Removal

According to the social media company, the service has taken down problematic content and prohibited related keywords and search suggestions. The organization said it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Digital Trading Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at home.

After minutes of joining one group, a seller shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Inside these communities, messages display black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they cannot confirm. Even if the science behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly significant health risks”.